Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells
about
Potentiating cancer immunotherapy using an oncolytic virusVesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancerEmerging role of Natural killer cells in oncolytic virotherapyOncolytic viruses as anticancer vaccinesMechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapyActivation of cytotoxic and regulatory functions of NK cells by Sindbis viral vectorsOncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.Vesicular stomatitis virus infection promotes immune evasion by preventing NKG2D-ligand surface expressionIdentification of genetically modified Maraba virus as an oncolytic rhabdovirus.Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells.Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma.Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer CellsCD8(+) T-cell Immune Evasion Enables Oncolytic Virus ImmunotherapyRoles of natural killer cells in antiviral immunityNK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors.Myeloid-derived suppressor cells as a vehicle for tumor-specific oncolytic viral therapy.Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma.Antifibrotic properties of transarterial oncolytic VSV therapy for hepatocellular carcinoma in rats with thioacetamide-induced liver fibrosis.Pharmacologic and chemical adjuvants in tumor virotherapy.The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon.Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways.Replicating viral vectors for cancer therapy: strategies to synergize with host immune responses.Sorting Out Pandora's Box: Discerning the Dynamic Roles of Liver Microenvironment in Oncolytic Virus Therapy for Hepatocellular Carcinoma.Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma.PET imaging of oncolytic VSV expressing the mutant HSV-1 thymidine kinase transgene in a preclinical HCC rat model.Poliovirus Receptor: More than a simple viral receptor.Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy.Evaluation of vesicular stomatitis virus mutant as an oncolytic agent against prostate cancer.Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy.Herpesvirus Evasion of Natural Killer Cells.Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil".
P2860
Q24628810-93667FB7-9031-4753-8302-38741C636B56Q27021839-19888F5E-D2BA-4052-8448-41225A8199ECQ27025330-5BBE12BB-384C-42A6-9E94-63471C3E263DQ27025600-243FFC28-39C1-43CC-B578-EB9377D8CAE0Q28083766-8F13D52C-1036-427D-8970-880798C2A4FFQ28744029-F85162E0-CA99-43A4-9DFA-DD767CB9A4A8Q33906116-19AF6DF3-7FC8-4CBD-9650-00D71E1E74DAQ33999130-BC4BA029-C9CF-43E9-9B67-93C5D8311811Q34080860-EE4C3C3F-95BF-4172-96AA-ACBDEA2A97A6Q34526520-5E4EBD45-6424-436E-B217-001DB3933827Q35665220-48B89B1F-5972-4DF2-9EAF-A296DDF4A1C0Q35687743-F8AE6203-C418-4FED-85E2-F53C2F8794A7Q36753953-6D1AC115-793D-44A7-BE68-7D7373533A9EQ36767761-F2B372A5-BD3B-4789-B912-8F30E263BAFFQ36890816-AF8D1B26-D4EC-4A72-842D-2A4719E550E0Q37100179-68EE057B-0159-4373-877D-63956D275588Q37123143-BA5A371C-45D4-4A82-8130-49B277DD6687Q37316860-87CF750B-2953-4F88-AABD-40A2EFEE6D58Q37492540-72DEF18C-BBC1-4429-AFA7-1BEC4B18B259Q37561072-0454C151-9C75-425F-BF39-569C7229B2D8Q37564490-FEC54E23-DD5E-4177-BC53-852DAEE76A30Q37933439-1E13A06C-636B-4F68-918D-C2E34E0B2507Q38209337-16A52B30-995A-4477-AFAA-FE04B6185A66Q39413447-B60E61C5-8581-4380-98CC-FB4CA80E004EQ39600108-4058AE60-2F7F-408E-91E9-6EBFAFB5C42FQ40058557-8FED3443-7E95-4DBF-9F31-E27A7B37448BQ40725309-55BEAA84-9130-4BCF-8ADF-5BD0EAC92F3DQ41379521-1506BBB1-35F2-4B77-9DFE-FB98F47865A7Q52688581-97655EF7-2114-4D8C-AA65-3338BE81A532Q54255834-F0861ECE-2343-4D9A-9C2D-E39C74FAE30EQ54378300-3A1885EC-66FA-4630-89D6-A03D05E63512
P2860
Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Enhanced oncolytic potency of ...... inhibition of NK and NKT cells
@ast
Enhanced oncolytic potency of ...... inhibition of NK and NKT cells
@en
Enhanced oncolytic potency of ...... inhibition of NK and NKT cells
@nl
type
label
Enhanced oncolytic potency of ...... inhibition of NK and NKT cells
@ast
Enhanced oncolytic potency of ...... inhibition of NK and NKT cells
@en
Enhanced oncolytic potency of ...... inhibition of NK and NKT cells
@nl
prefLabel
Enhanced oncolytic potency of ...... inhibition of NK and NKT cells
@ast
Enhanced oncolytic potency of ...... inhibition of NK and NKT cells
@en
Enhanced oncolytic potency of ...... inhibition of NK and NKT cells
@nl
P2093
P2860
P50
P356
P1433
P1476
Enhanced oncolytic potency of ...... inhibition of NK and NKT cells
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2008.74
P577
2008-10-10T00:00:00Z
P5875
P6179
1004847191